{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:59:40Z","timestamp":1789729180298,"version":"4.0.1"},"reference-count":35,"publisher":"BMJ","issue":"9","funder":[{"name":"Spanish Ministry of Health, Social Policy and Equity"},{"name":"Spanish Ministry of Economy and Competitiveness"},{"name":"Regional Ministry of Health of Andalusia"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,7,4]]},"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There is a need to find alternatives to the use of human donor corneas in transplants because of the limited availability of donor organs, the incidence of graft complications, as well as the inability to successfully perform corneal transplant in patients presenting limbal deficiency, neo-vascularized or thin corneas, etc. We have designed a clinical trial to test a nanostructured fibrin-agarose corneal substitute combining allogeneic cells that mimics the anterior human native cornea in terms of optical, mechanical and biological behaviour.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a phase I-II, randomised, controlled, open-label clinical trial, currently ongoing in ten Spanish hospitals, to evaluate the safety and feasibility, as well as clinical efficacy evidence, of this bioengineered human corneal substitute in adults with severe trophic corneal ulcers refractory to conventional treatment, or with sequelae of previous ulcers. In the initial phase of the trial (n=5), patients were sequentially recruited, with a safety period of 45 days, receiving the bioengineered corneal graft. In the second phase of the trial (currently ongoing), subjects are block randomised (2:1) to receive either the corneal graft (n=10), or amniotic membrane (n=5), as the control treatment. Adverse events, implant status, infection signs and induced neovascularization are evaluated as determinants of safety and feasibility of the bioengineered graft (main outcomes). Study endpoints are measured along a follow-up period of 24 months, including 27 post-implant assessment visits according to a decreasing frequency. Intention to treat, and per protocol, and safety analysis will be performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial protocol received written approval by the corresponding Ethics Committee and the Spanish Regulatory Authority and is currently recruiting subjects. On completion of the trial, manuscripts with the results of phases I and II of the study will be published in a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      CT.gov identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01765244\">NCT01765244<\/jats:ext-link>\n                      (Jan2013). EudraCT number: 2010-024290-40 (Dec2012).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-016487","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T20:10:18Z","timestamp":1506370218000},"page":"e016487","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["A study protocol for a multicentre randomised clinical trial evaluating the safety and feasibility of a bioengineered human allogeneic nanostructured anterior cornea in patients with advanced corneal trophic ulcers refractory to conventional treatment"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct01765244","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01765244","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Miguel","family":"Gonz\u00e1lez-Andrades","sequence":"first","affiliation":[{"name":"Department of Ophthalmology Service, University Hospital Complex of Granada (San Cecilio and Virgen de las Nieves Hospitals), Granada, Spain"},{"name":"Tissue Engineering Group, Department of Histology, University of Granada, Granada, Spain"},{"name":"Department of Ophthalmology, Schepens Eye Research Institute of Massachusetts, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Mata","sequence":"additional","affiliation":[{"name":"Andalusian Initiative for Advanced Therapies, Junta de Andaluc\u00eda, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"Gonz\u00e1lez-Gallardo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Service, University Hospital Complex of Granada (San Cecilio and Virgen de las Nieves Hospitals), Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Medialdea","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Service, University Hospital Complex of Granada (San Cecilio and Virgen de las Nieves Hospitals), Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Arias-Santiago","sequence":"additional","affiliation":[{"name":"Cell Therapy and Tissue Engineering Unit, University Hospital Complex of Granada (Virgen de las Nieves Hospital), Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Mart\u00ednez-Atienza","sequence":"additional","affiliation":[{"name":"Andalusian Initiative for Advanced Therapies, Junta de Andaluc\u00eda, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ruiz-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Cell Therapy and Tissue Engineering Unit, University Hospital Complex of Granada (Virgen de las Nieves Hospital), Granada, Spain"},{"name":"PhD program Clinical Medicine and Public Health, University of Granada, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"P\u00e9rez-Fajardo","sequence":"additional","affiliation":[{"name":"Andalusian Initiative for Advanced Therapies, Junta de Andaluc\u00eda, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lizana-Moreno","sequence":"additional","affiliation":[{"name":"Cell Therapy and Tissue Engineering Unit, University Hospital Complex of Granada (Virgen de las Nieves Hospital), Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Garz\u00f3n","sequence":"additional","affiliation":[{"name":"Tissue Engineering Group, Department of Histology, University of Granada, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Campos","sequence":"additional","affiliation":[{"name":"Tissue Engineering Group, Department of Histology, University of Granada, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Alaminos","sequence":"additional","affiliation":[{"name":"Tissue Engineering Group, Department of Histology, University of Granada, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Carmona","sequence":"additional","affiliation":[{"name":"Andalusian Initiative for Advanced Therapies, Junta de Andaluc\u00eda, Seville, Spain"},{"name":"PhD program Clinical Medicine and Public Health, University of Granada, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natividad","family":"Cuende","sequence":"additional","affiliation":[{"name":"Andalusian Initiative for Advanced Therapies, Junta de Andaluc\u00eda, Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,9,24]]},"reference":[{"key":"2025121222505433000_7.9.e016487.1","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","author":"Resnikoff","year":"2004","journal-title":"Bull World Health Organ"},{"key":"2025121222505433000_7.9.e016487.2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300539"},{"key":"2025121222505433000_7.9.e016487.3","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.100540"},{"key":"2025121222505433000_7.9.e016487.4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701968"},{"key":"2025121222505433000_7.9.e016487.5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global survey of corneal transplantation and Eye Banking","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2025121222505433000_7.9.e016487.6","first-page":"3","article-title":"Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment","volume":"47","author":"Dua","year":"1999","journal-title":"Indian J Ophthalmol"},{"key":"2025121222505433000_7.9.e016487.7","doi-asserted-by":"crossref","unstructured":"Brunette I , Roberts CJ , Vidal F , et al . Alternatives to eye bank native tissue for corneal stromal replacement. Prog Retin Eye Res. In Press. 2017.doi:10.1016\/j.preteyeres.2017.04.002","DOI":"10.1016\/j.preteyeres.2017.04.002"},{"key":"2025121222505433000_7.9.e016487.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-8062.2008.00083.x"},{"key":"2025121222505433000_7.9.e016487.9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001022"},{"key":"2025121222505433000_7.9.e016487.10","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.biomaterials.2013.11.079","article-title":"Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold","volume":"35","author":"Fagerholm","year":"2014","journal-title":"Biomaterials"},{"key":"2025121222505433000_7.9.e016487.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905955"},{"key":"2025121222505433000_7.9.e016487.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.12.042"},{"key":"2025121222505433000_7.9.e016487.13","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/ICO.0000000000000933","article-title":"Long-Term Outcomes of the Boston type I Keratoprosthesis in the management of corneal limbal stem cell deficiency","volume":"35","author":"Aravena","year":"2016","journal-title":"Cornea"},{"key":"2025121222505433000_7.9.e016487.14","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1647"},{"key":"2025121222505433000_7.9.e016487.15","doi-asserted-by":"publisher","DOI":"10.1002\/term.178"},{"key":"2025121222505433000_7.9.e016487.16","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.jmbbm.2011.06.013","article-title":"Investigating a novel nanostructured fibrin-agarose biomaterial for human cornea tissue engineering: rheological properties","volume":"4","author":"Ionescu","year":"2011","journal-title":"J Mech Behav Biomed Mater"},{"key":"2025121222505433000_7.9.e016487.17","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31821bdfd4"},{"key":"2025121222505433000_7.9.e016487.18","doi-asserted-by":"crossref","first-page":"015015","DOI":"10.1088\/1748-6041\/11\/1\/015015","article-title":"Usefulness of a bioengineered oral mucosa model for preventing palate bone alterations in rabbits with a mucoperiostial defect","volume":"11","author":"Fern\u00e1ndez-Valad\u00e9s-G\u00e1mez","year":"2016","journal-title":"Biomed Mater"},{"key":"2025121222505433000_7.9.e016487.19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000330682","article-title":"Epithelial and stromal developmental patterns in a novel substitute of the human skin generated with fibrin-agarose biomaterials","volume":"196","author":"Carriel","year":"2012","journal-title":"Cells Tissues Organs"},{"key":"2025121222505433000_7.9.e016487.20","doi-asserted-by":"crossref","first-page":"026022","DOI":"10.1088\/1741-2560\/10\/2\/026022","article-title":"Combination of fibrin-agarose hydrogels and adipose-derived mesenchymal stem cells for peripheral nerve regeneration","volume":"10","author":"Carriel","year":"2013","journal-title":"J Neural Eng"},{"key":"2025121222505433000_7.9.e016487.21","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181ca3650"},{"key":"2025121222505433000_7.9.e016487.22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/805876","article-title":"Congenital corneal anesthesia and neurotrophic keratitis: diagnosis and management","volume":"2015","author":"Mantelli","year":"2015","journal-title":"Biomed Res Int"},{"key":"2025121222505433000_7.9.e016487.23","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32832b758f"},{"key":"2025121222505433000_7.9.e016487.24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700616"},{"issue":"Suppl 11","key":"2025121222505433000_7.9.e016487.25","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/ICO.0000000000000587","article-title":"Potential new modes of treatment of Neurotrophic Keratopathy","volume":"34","author":"Yanai","year":"2015","journal-title":"Cornea"},{"key":"2025121222505433000_7.9.e016487.26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1011597332277","article-title":"Preserved amniotic membrane transplantation for Conjunctival surface reconstruction","volume":"2","author":"Prabhasawat","year":"2001","journal-title":"Cell Tissue Bank"},{"key":"2025121222505433000_7.9.e016487.27","unstructured":"Krachmer JH , Mannis MJ , Holland EJ , et al . Cornea. St Louis: Elsevier Health Sciences, 2010."},{"key":"2025121222505433000_7.9.e016487.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.10.029"},{"key":"2025121222505433000_7.9.e016487.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.09.013"},{"key":"2025121222505433000_7.9.e016487.30","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2008.140"},{"key":"2025121222505433000_7.9.e016487.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.01.001"},{"key":"2025121222505433000_7.9.e016487.32","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.jcyt.2017.02.330","article-title":"Optimization of the manufacturing process of an artificial human cornea under GMP guidelines","volume":"19","author":"Lizana-Moreno","year":"2017","journal-title":"Cytotherapy"},{"key":"2025121222505433000_7.9.e016487.33","unstructured":"Mackie IA . Neuroparalytic keratitis. In: Fraunfelder FRF , Meyer SM , eds. Current ocular therapy. Philadelphia, PA, USA: WB Saunders, 1995."},{"key":"2025121222505433000_7.9.e016487.34","first-page":"506","article-title":"SPIRIT 2013 Statement: defining standard protocol items for clinical trials","volume":"38","author":"Chan","year":"2015","journal-title":"Rev Panam Salud Publica"},{"key":"2025121222505433000_7.9.e016487.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2011.09.004"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-016487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:51:04Z","timestamp":1765608664000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-016487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,24]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1136\/bmjopen-2017-016487"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-016487","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}